Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108047151B details a novel route for Gadobutrol using tert-butyl bromoacetate, offering high purity and scalable production for MRI contrast agents.
Advanced low-temperature synthesis of 4-methoxy ethyl acetoacetate via patent CN107311861A. Delivers high-purity pharmaceutical intermediates with optimized supply chain reliability.
Patent CN108137587A details a novel electrochemical recycling method for high-purity naphthyridine intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN112479853A reveals a novel resin-catalyzed route for high-purity D-2-chloropropionyl chloride, offering significant cost reduction in API manufacturing and scalable production.
Patent CN116640108A reveals metal-free synthesis for high-purity 2-vinyl chroman compounds ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthetic route for Marbofloxacin offers high yield and reduced pollution. Ideal for reliable veterinary drugs supplier seeking cost reduction.
New patent CN107522718A reveals high-yield Marbofloxacin synthesis reducing pollution and costs for reliable veterinary drugs supply chains globally.
Patent CN1679586A reveals a novel mirtazapine synthesis reducing base usage and improving crystallization safety for cost-effective pharmaceutical manufacturing.
Novel one-pot synthesis for Linagliptin intermediate reduces steps and improves yield. Reliable supplier for pharmaceutical manufacturing scale-up and cost efficiency.
Patent CN116947700B reveals liquid ammonia amidation for quinolone intermediates. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN101052633A details efficient indazole synthesis for kinase inhibitors. Discover cost reduction in API manufacturing and scalable production methods.
Patent CN1791602A reveals a 100% selective route for famciclovir intermediates, eliminating explosive catalysts and reducing purification costs for reliable supply chains.
Patent CN1033391C details advanced catalytic routes for metabolically stable beta-carboline derivatives, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN103554016B reveals enzymatic synthesis for high-purity API intermediates. Achieve substantial cost reduction and supply chain reliability with scalable green chemistry solutions.
Patent CN101973869A reveals a green 3-step synthesis for Flurbiprofen. Discover cost-effective manufacturing and high-purity supply chain solutions.
Discover a novel 3-step synthesis for Flurbiprofen intermediates using palladium catalysis. Achieve high purity, green chemistry compliance, and reduced manufacturing costs.
Patent CN104710368A details a high-yield Pd-catalyzed route for 2-benzoyl quinazolinone. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105039433A reveals high-yield yeast catalysis. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105906628B reveals a greener Linagliptin synthesis route eliminating toxic reagents, ensuring high purity and cost reduction in API manufacturing for global supply chains.
Patent CN105087670A details high-yield biocatalytic synthesis. Offers supply chain stability and cost reduction in chiral intermediate manufacturing for global partners seeking reliable pharmaceutical intermediate supplier.